Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

BACKGROUND: Mesenchymal stromal cells (MSC) may serve as an attractive therapy in renal transplantation due to their immunosuppressive and reparative properties. While most studies have used autologous MSCs, allogeneic MSCs offer the advantage of immediate availability for clinical use. This is of m...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Transl Med
Main Authors: Reinders, Marlies E. J., Dreyer, Geertje J., Bank, Jonna R., Roelofs, Helene, Heidt, Sebastiaan, Roelen, Dave L., Zandvliet, Maarten L., Huurman, Volkert A. L., Fibbe, Wim E., van Kooten, Cees, Claas, Frans H. J., Rabelink, Ton J., de Fijter, Johan W.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4632480/
https://ncbi.nlm.nih.gov/pubmed/26537851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0700-0
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki